Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their Ayurvedic treatment of psoriasis using Psorogrit tablets and Divya Taila.

Sen. Tammy Duckworth (D-Ill.) a former Black Hawk helicopter pilot and combat veteran, said Secretary of Defense Pete Hegseth’s “singular stupidity” is putting troops in harm’s way and ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable effect for a drug ...

BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study. The randomized, ...

HealthDay News — Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed, according to a study recently ...

In a major milestone for Patanjali, its research on Ayurvedic cure for psoriasis has been published in the internationally acclaimed Journal of Inflammation Research, a Taylor & Francis publication.